Carrhae Capital LLP Taro Pharmaceutical Industries LTD Transaction History

Carrhae Capital LLP

  • $876 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2015

Nov 27, 2024
SELL
N/A
-21,300 Closed
0 $0
Q3 2015

Nov 27, 2024
SELL
N/A
-700 Reduced 3.18%
21,300 $3.04 Billion
Q2 2015

Nov 27, 2024
BUY
N/A
22,000
22,000 $3.16 Billion

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Carrhae Capital LLP Portfolio

Follow Carrhae Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carrhae Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Carrhae Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email